Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-10-14 00:00:00 ET · period of report 2022-10-12 · accession 0000899243-22-033673 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-14 | 2022-10-12+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $2.78 | -418.3K | 25.59M | -2% | -$1.16M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-10-13 | S | D | 207,271 | $2.74 | 25,380,378 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-10-12 | S | D | 211,066 | $2.81 | 25,587,649 | D | — | — |